These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26401644)

  • 1. Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
    Rathod PS; Kundargi R; Pallavi VR; Vijay CR; Devi UK; Bafna UD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1737-41. PubMed ID: 26401644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
    Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB
    Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.
    Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y
    Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
    Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
    Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
    Rattanaburi A; Boonyapipat S; Supasinth Y
    Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
    Cagayan MS
    J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
    Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
    Byun SW; Park TC; Bae SN
    Int J Gynecol Cancer; 2016 May; 26(4):790-5. PubMed ID: 27057813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
    Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.